98%
921
2 minutes
20
A set of 220 inhibitors belonging to different structure classes and having HIV-1 integrase activity were collected along with their experimental pIC values. Geometries of all the inhibitors were fully optimized using B3LYP/6-31 + G(d) level of theory. These ligands were docked against 4 different HIV-1 integrase receptors (PDB IDs: 4LH5, 5KRS, 3ZSQ and 3ZSV). 30 docked poses were generated for all 220 inhibitors and ligand interaction of the first docked pose and the docked pose with the highest score were analysed. Residue GLU170 of 4LH5 receptor shows the highest number of interactions followed by ALA169, GLN168, HIS171 and ASP167 residues. Hydrogen bonding and stacking are mainly responsible for the interactions of these inhibitors with the receptor. We performed Molecular Dynamics (MD) simulation to observe the root-mean-square deviation (RMSD), for measure the average change of displacement between the atoms for a particular frame with respect to a reference and The Root Mean Square Fluctuation (RMSF) for characterization of local changes along the protein chain of the docked complexes. Analogue based models were generated to predict the pIC values for integrase inhibitors using various types of descriptors such as constitutional, geometrical, topological, quantum chemical and docking based descriptors. The best models were selected on the basis of statistical parameters and were validated by training and test set division. A few new inhibitors were designed on the basis of structure activity relationship and their pIC values were predicted using the generated models. All the designed new inhibitors a very high potential and may be used as potent inhibitors of HIV integrase. These models may be useful for further design and development of new and potent HIV integrase inhibitors.Communicated by Ramaswamy H. Sarma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/07391102.2023.2171129 | DOI Listing |
Viruses
August 2025
Andevir, University Bordeaux, CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33000 Bordeaux, France.
Integrase is a key protein during HIV-1 replication as it catalyzes the integration of viral DNA into the host DNA. After several decades of research, highly potent and selective active site inhibitors have emerged. The new challenge is now to develop molecules with an original mode of action, targeting integrase out of its catalytic site.
View Article and Find Full Text PDFComput Biol Chem
December 2025
Amity Institute of Biotechnology, Amity University Maharashtra, Bhatan, Panvel, Navi Mumbai, Maharashtra 410206, India; Center for Drug Discovery and Development (CD3), Amity University Maharashtra, Bhatan, Panvel, Navi Mumbai, Maharashtra 410206, India. Electronic address:
HIV-1 drug resistance remains a major challenge in antiretroviral therapy, highlighting the need for new and more effective inhibitors. This study explores Zinc C293 as a potential dual inhibitor targeting two key HIV-1 enzymes: integrase (IN) and reverse transcriptase (RT). Initially identified through pharmacophore-based virtual screening, Zinc C293 was further analyzed using molecular docking and molecular dynamics (MD) simulations to understand its stability and interactions with IN.
View Article and Find Full Text PDFInt J Biol Macromol
July 2025
Biomedical Sciences and Molecular Biology, College of Medicine and Dentistry, James Cook University, Douglas, QLD 4811, Australia. Electronic address:
Human immunodeficiency virus (HIV) integrase is an important antiretroviral drug target. However, growing resistance towards integrase strand transfer inhibitors will need new drugs with distinct mechanisms of action. Highly efficient integrase activity assays are key tools for drug screening campaigns and the development of therapies addressing these resistance challenges.
View Article and Find Full Text PDFViruses
May 2025
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
HIV-1 integrase (IN), an essential viral protein that catalyzes integration, also influences non-integration functions such as particle production and morphogenesis. The mechanism by which non-integration functions are mediated is not completely understood. Several factors influence these non-integration functions, including the ability of IN to bind to viral RNA.
View Article and Find Full Text PDFPharmaceuticals (Basel)
May 2025
Department of Health Informatics, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
This study aimed to develop a predictive model to classify and rank highly active compounds that inhibit HIV-1 integrase (IN). : A total of 2271 potential HIV-1 inhibitors were selected from the ChEMBL database. The most relevant molecular descriptors were identified using a hybrid GA-SVM-RFE approach.
View Article and Find Full Text PDF